NCT00840125View on ClinicalTrials.gov

Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

August 31, 2011

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

erlotinib

150mg tablet daily

DRUG

docetaxel

30 mg/m2 days 1,8 of 22 days cycles, up to 6 cycles

Trial Locations (1)

44281

Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER